drugset / Trial / NCT01014585

Discontinuation Study of the Durability of Effect of Milnacipran for the Treatment of Fibromyalgia

NCT01014585

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the durability of effect of milnacipran for the treatment of fibromyalgia in patients receiving long-term milnacipran treatment and to characterize the effects of milnacipran on multiple symptoms of fibromyalgia, as demonstrated by changes in symptoms following the discontinuation of milnacipran.

Timeline

Start
2009-11
Primary completion
2010-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Milnacipran Other / unclassified Oral

Indications